Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05609669 · ClinicalTrials.gov registry record · NA

Continuous And Data-drivEN CarE (CADENCE) Pilot

A NA study of Opioid Use Disorder and Pregnancy Related, sponsored by University of South Florida.

Active
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT05609669 is a NA study of Opioid Use Disorder and Pregnancy Related that is active but no longer recruiting, run by University of South Florida. The registered enrollment target is 10 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05609669, a NA study of Opioid Use Disorder and Pregnancy Related, is active but no longer recruiting, sponsored by University of South Florida.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The proposed project seeks to use public health and clinical data on opioid use disorders (OUD) outcomes for mother and infants, which is the leading cause of death to mothers one year after deliver and can lead to neonatal withdrawal syndrome (NOWS) and other poor outcomes. Insufficient or incomplete data about OUD and lack of integrated programs for OUD treatment during pregnancy can be barriers to providing optimal care to mothers and infants.

Interventions

  • OTHER CADENCE program

Study Locations (1)

Florida

  • University of South Florida/Tampa General Hospital - Tampa

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-08-23
Est. Completion 2027-09-30
Phase NA

Sponsor

University of South Florida

252 total trials

What the Registry Record Tells You About NCT05609669

The ClinicalTrials.gov registry entry for NCT05609669 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which CADENCE program is the first listed.

NCT05609669 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05609669 about?

NCT05609669 is a clinical study titled "Continuous And Data-drivEN CarE (CADENCE) Pilot". The proposed project seeks to use public health and clinical data on opioid use disorders (OUD) outcomes for mother and infants, which is the leading cause of death to mothers one year after deliver and can lead to neonatal withdrawal syndrome (NOWS) and other poor outcomes. Insufficient or incomple...

What is the current status of trial NCT05609669?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-08-23. Estimated completion is 2027-09-30.

What conditions does trial NCT05609669 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Pregnancy Related.

What interventions are being tested in trial NCT05609669?

The interventions under investigation include: CADENCE program (OTHER).

Who is sponsoring clinical trial NCT05609669?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05609669 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.